340B Drug Pricing Program
On March 6, AHA, others filed an amicus brief opposing the Sonafi 340B rebate model.
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to affirm a decision by the U.S.
AHA, others file amicus brief in Fourth Circuit in support of West Virginia contract pharmacy law.
AHA, others file amicus brief opposing Eli Lilly, Bristol Meyers Squibb and Novartis 340B rebate models.
AHA, others file amicus brief supporting HRSA decision to reject 340B rebate model policies.
The AHA Feb. 28 filed a friend-of-the-court brief (https://www.aha.org/amicus-brief/2025-02-28-aha-others-file-amicus-brief-opposing-jj-340b-rebate-model) in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision…
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. District Court for the District of Columbia, urging the court to uphold the Health Resources and Services Administration’s decision to reject Johnson & Johnson’s proposed 340B rebate model in a lawsuit brought by J&J to bar the…
AHA, others file amicus brief opposing J&J 340B rebate model.
AHA, others file amicus brief in Fourth Circuit in support of Maryland 340B contract pharmacy law.
AHA President and CEO Rick Pollack joined AHA’s Chad Golder, senior vice president and general counsel, Travis Robey, vice president of political affairs, and Shannon Wu, director of payment policy, for a discussion on the ever-shifting landscape of health care affairs on Capitol Hill.